Bone Marrow Transplant program among five centers earning BCBS Center-plus distinctionTweet
The Hollings Cancer Center Adult and Pediatric Blood and Marrow Transplant Program was granted official designation as a Blue Distinction Center+ for Transplants as of June 15, making it one of only five centers nationwide with the Center+ distinction.
According to BlueCross BlueShield, Blue Distinction Centers for Transplants have demonstrated their commitment to quality care, resulting in better overall outcomes for transplant patients. Blue Distinction Centers+ are hospitals recognized for their expertise and efficiency in delivering specialty care.
Each facility meets stringent clinical criteria, established in collaboration with expert physicians' and medical organizations' recommendations, including the Center for International Blood and Marrow Transplant Research, the Scientific Registry of Transplant Recipients and the Foundation for the Accreditation of Cellular Therapy.
The facilities are subject to periodic re-evaluation as criteria continue to evolve. Blue Distinction Centers for Transplants help simplify the administrative process involved in the complex care involved in transplants so that patients, their families and physicians can focus on the medical issues.
According to Robert K. Stuart, M.D., MUSC BMT Program director,“This designation represents a big win for our BlueCross BlueShield patients, their referring physicians, and the BMT staff. We’re proud to be recognized among such an elite group of transplant centers.”
August 1, 2014